These findings suggest that an effective whole cell vaccine in a mouse neuroblastoma model induces organ specific autoimmune responses and when CD24- Fc is appropriately administered, the irAE can be reduced without exacerbating tumor growth or impeding tumor immunity. This evidence concerns the gene CD24 and neuroblastoma.